Additionally, fasting blood sugar levels improved without weight loss in this short course of 1.8 mg liraglutide therapy. No significant changes were noted in fructosamine, HbA1c, lipid profiles, blood pressure or anthropometric measurements, such as BMI and fat mass, as expected with the short ...